The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Intensified Chemotherapy in CRC After Resection of Liver Metastases
Official Title: Randomized Phase II Trial Followed by Phase III Trial With Molecular Biology Study, Comparing a Standard Bi-therapy vs 3 Arms of Intensified Chemotherapy in Patients With Unresectable or Not Optimally Resectable Colorectal Cancer Liver Metastases.
Study ID: NCT00208260
Brief Summary: Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CRLC Val d'Aurelle, Montpellier, , France
Name: Marc YCHOU, MD, PhD
Affiliation: CRLC Val d'Aurelle
Role: PRINCIPAL_INVESTIGATOR
Name: Michel RIVOIRE, MD
Affiliation: CRLC Leon Berard - Lyon
Role: STUDY_CHAIR